A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

NCT01247194 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Genotype 1 Hepatitis C Virus Infection

Interventions

DRUG: PPI-461
DRUG: Placebo

Sponsor

Presidio Pharmaceuticals, Inc.